Jorge Quiroz, MD, MBA

Dr. Jorge Quiroz is the Chief Development and Strategy Officer at Gilgamesh Pharmaceuticals, where he leads the clinical and regulatory strategy for the company’s portfolio of innovative psychiatric therapies. He brings over 20 years of experience in drug development—spanning roles at the NIH, Johnson & Johnson, and Roche—covering the full spectrum from early-stage clinical research (IND filings and proof-of-concept studies) to registrational programs (NDA and sNDA submissions) for small molecules and gene therapies. Dr. Quiroz also holds an MBA from Columbia University/London Business School.